Crossmark

Real-World Adherence to Tetrabenazine or Deutetrabenazine Among Patients With Huntington’s Disease: A Retrospective Database Analysis

Published Online: 2021-12-14

Published Print: 2022-03

Authors

Claassen, Daniel O.

Ayyagari, Rajeev

Garcia-Horton, Viviana

Zhang, Su

Alexander, Jessica

Leo, Sam
Funding

Funding for this research was provided by:

Teva Pharmaceutical Industries Ltd., Tel Aviv, Israel
License Information

Text and Data Mining valid from 2021-12-14

Version of Record valid from 2021-12-14
More Information

Article History

Received: 13 September 2021

Accepted: 26 November 2021

First Online: 14 December 2021

Document is current